Publications by authors named "Tine Cuppens"

9Publications

Osimertinib in patients with advanced/metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer - the Belgian ASTRIS data.

Acta Clin Belg 2020 Jan 14:1-8. Epub 2020 Jan 14.

Respiratory Oncology Unit, Department of Respiratory Diseases, University Hospitals KU Leuven, Catholic University Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/17843286.2019.1708125DOI Listing
January 2020

Establishment and characterization of uterine sarcoma and carcinosarcoma patient-derived xenograft models.

Gynecol Oncol 2017 09 16;146(3):538-545. Epub 2017 Jun 16.

KU Leuven - University of Leuven, Department of Oncology, Gynaecologic Oncology, B-3000 Leuven, Belgium; Centre for Gynecologic Oncology Amsterdam (CGOA), Antoni Van Leeuwenhoek - Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands; University Hospitals Leuven, Department of Obstetrics and Gynaecology, B-3000 Leuven, Belgium. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ygyno.2017.06.005DOI Listing
September 2017

Genomic Characterisation and Response to Trastuzumab and Paclitaxel in Advanced or Recurrent HER2-positive Endometrial Carcinoma.

Anticancer Res 2016 10;36(10):5381-5384

Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, KU Leuven - University of Leuven, University Hospitals Leuven, Leuven, Belgium.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21873/anticanres.11112DOI Listing
October 2016

Potential Therapeutic Targets in Uterine Sarcomas.

Sarcoma 2015 21;2015:243298. Epub 2015 Oct 21.

Department of Oncology, Gynaecologic Oncology, KU Leuven (University of Leuven), 3000 Leuven, Belgium ; Department of Obstetrics and Gynaecology, University Hospitals Leuven, 3000 Leuven, Belgium ; Center for Gynaecologic Oncology Amsterdam (CGOA), Antoni van Leeuwenhoek-Netherlands Cancer Institute, 1066 CX Amsterdam, Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2015/243298DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632006PMC
November 2015

Growth differentiation factor-15 as biomarker in uterine sarcomas.

Int J Gynecol Cancer 2014 Feb;24(2):252-9

*Department of Obstetrics and Gynecology, Haukeland University Hospital, and †Department of Clinical Medicine, The University of Bergen, Bergen, Norway; ‡Gynecologic Oncology, University Hospitals Leuven, Leuven, Belgium; §Gynecologic Oncology, University Hospitals Leuven & Department of Oncology, KU Leuven, Leuven, Belgium; ∥Department of Gynecology, Oslo University Hospital, Ulleval, and ¶Faculty of Medicine, University of Oslo, Oslo, Norway.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/IGC.0000000000000037DOI Listing
February 2014